(Q43645616)

English

Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients

scientific article published in January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

J-H Cho

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Y-D Yoon

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J-Y Park

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

E-J Song

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J-Y Choi

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S-H Yoon

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S-H Park

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Y-L Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C-D Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

109-114

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Detection of the four sequence variations of MDR1 gene using TaqMan® MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

CYP3A variation and the evolution of salt-sensitivity variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.11.004

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2011.11.004

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43645616&oldid=2102293597"